Korro Bio, Inc. (KRRO)
NASDAQ: KRRO · Real-Time Price · USD
60.13
+1.97 (3.39%)
Nov 4, 2024, 4:00 PM EST - Market closed
Korro Bio Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for Korro Bio stock have an average target of 134.6, with a low estimate of 105 and a high estimate of 180. The average target predicts an increase of 123.85% from the current stock price of 60.13.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Korro Bio stock from 6 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 2 | 2 |
| Buy | 3 | 3 | 4 | 4 | 4 | 4 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 5 | 5 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Buy Maintains $95 → $105 | Buy | Maintains | $95 → $105 | +74.62% | Oct 21, 2024 |
| Raymond James | Raymond James | Strong Buy Initiates $153 | Strong Buy | Initiates | $153 | +154.45% | Oct 21, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $100 → $115 | Strong Buy | Maintains | $100 → $115 | +91.25% | Oct 18, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $95 | Buy | Reiterates | $95 | +57.99% | Sep 19, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $100 | Strong Buy | Reiterates | $100 | +66.31% | Sep 17, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-9.87
from -53.08
EPS Next Year
-10.31
from -9.87
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | n/a | n/a | n/a | ||
| Avg | n/a | n/a | n/a | ||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -8.68 | -9.16 | -8.40 | ||
| Avg | -9.87 | -10.31 | -9.85 | ||
| Low | -10.35 | -11.83 | -12.74 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.